Abstract 4366111: Neck Adiposity Measured on Pre-therapy Oncologic Computed Tomography Scans Predicts the Development of Radiation Therapy-induced Carotid Artery Disease in Patients with Head and Neck Cancer

D Dhawal Sanjay Bandrey (MD Anderson Cancer Center, Houston , Texas, United States) B Bhumiben Patel (MD Anderson Cancer Center, Houston, Texas, United States) P Patrik Joan Van Bergen Diaz (University of Barcelona, Barcelona, Spain) G Gabrielle Mbagwu (MD Anderson Cancer Center, Houston, Texas, United States) J Jennifer Shen (MD Anderson Cancer Center, Pearland, Texas, United States) T Taher Kapadia (MD Anderson Cancer Center, Houston , Texas, United States) S Stephen Patin (MD Anderson Cancer Center, Houston , Texas, United States) A Andres Hughes (MD Anderson Cancer Center, Houston, Texas, United States) J Juhee Song (UT MD Anderson Cancer Center, Houston, Texas, United States) J Junichi Abe (University of Texas MD Anderson Can, Houston, Texas, United States) R Ruitao Lin (MD Anderson Cancer Center, Houston, Texas, United States) A Amy Moreno (MD Anderson Cancer Center, Houston , Texas, United States) M Mohamed Naser K Kate Hutcheson D David Rosenthal (MD Anderson Cancer Center, Houston, Texas, United States) S Shaden Khalaf (UT MD Anderson Cancer Center, Houston, Texas, United States) C Cezar Iliescu E Elie Mouhayar (MD Anderson Cancer Center, Houston, Texas, United States) A Anita Deswal C Clifton Fuller E Efstratios Koutroumpakis (UT MD Anderson Cancer Center, Houston, Texas, United States)

Abstract

Background: Bidirectional signaling between arteries and adjacent adipose tissue has been implicated in atherosclerosis progression. Adipose tissue characterization by CT imaging techniques has emerged as a novel risk-predicting tool for future cardiovascular events. This study aimed to evaluate whether neck adiposity at the time of cancer diagnosis is associated with the subsequent development of radiation therapy (RT) induced carotid artery disease (RICAD) in patients with head and neck cancer (HNC). Methods: Patients with HNC treated with RT at a tertiary center between 2005 and 2010 were identified. Oncologic CT scans of the neck performed for RT planning purposes were used to quantify adipose tissue and skeletal muscle mass at the C3 spinal level by SliceOmatic, version 5.0 Tomovision (Figure 1). Adipose tissue and skeletal muscle volumes were indexed to account for height. Fine-Gray competing risk regression models with stepwise forward selection were used to evaluate the association between baseline clinical and imaging characteristics with subsequent development of the composite event of new or worsened carotid atherosclerosis, carotid artery stenosis >50%, transient ischemic attack (TIA) or stroke. Results: Of 231 patients, 91% were male and 97% white, with a mean age of 74 ± 9 years. Prior to RT, 42% had hypertension, 28% dyslipidemia, 12% diabetes, and 3.5% prior stroke/TIA. At a median follow-up of 9.8 years (IQR 10.5), 42% developed new or worsened carotid atherosclerosis, 12% carotid stenosis >50%, and 6% stroke/TIA, while 39% expired. In the multivariable Fine-Gray analysis, neck adipose tissue index was significantly associated with the development of the composite event (HR 1.04 per unit increase, 95% CI 1.01–1.06, p = 0.0015). Baseline use of antiplatelet agents was also associated with the composite event (HR 2.18, 95% CI 1.41–3.36, p = 0.0004) while no significant association was noted with other characteristics such as age, traditional cardiovascular risk factors, prior atherosclerotic disease, statin use, RT dose and skeletal muscle mass. Conclusion: Neck adiposity was associated with RICAD in our cohort of HNC patients with long follow up, supporting the hypothesis of an interplay between inflamed perivascular adiposity and development of carotid artery disease post RT in survivors of HNC. Adipose tissue quantification using SOC oncologic CT scans may assist with patient risk stratification and guide surveillance.

Article Details

Journal Circulation
Volume / Issue Vol. 152, Issue Suppl_3
Published November 04, 2025
ISSN 0009-7322
Publisher Lippincott Williams & Wilkins

Journal Info

Circulation

Lippincott Williams & Wilkins

ISSN: 0009-7322 Health Sciences

Authors (21)

D

Dhawal Sanjay Bandrey

MD Anderson Cancer Center, Houston , Texas, United States

B

Bhumiben Patel

MD Anderson Cancer Center, Houston, Texas, United States

P

Patrik Joan Van Bergen Diaz

University of Barcelona, Barcelona, Spain

G

Gabrielle Mbagwu

MD Anderson Cancer Center, Houston, Texas, United States

J

Jennifer Shen

MD Anderson Cancer Center, Pearland, Texas, United States

T

Taher Kapadia

MD Anderson Cancer Center, Houston , Texas, United States

S

Stephen Patin

MD Anderson Cancer Center, Houston , Texas, United States

A

Andres Hughes

MD Anderson Cancer Center, Houston, Texas, United States

J

Juhee Song

UT MD Anderson Cancer Center, Houston, Texas, United States

J

Junichi Abe

University of Texas MD Anderson Can, Houston, Texas, United States

R

Ruitao Lin

MD Anderson Cancer Center, Houston, Texas, United States

A

Amy Moreno

MD Anderson Cancer Center, Houston , Texas, United States

M

Mohamed Naser

K

Kate Hutcheson

D

David Rosenthal

MD Anderson Cancer Center, Houston, Texas, United States

S

Shaden Khalaf

UT MD Anderson Cancer Center, Houston, Texas, United States

C

Cezar Iliescu

E

Elie Mouhayar

MD Anderson Cancer Center, Houston, Texas, United States

A

Anita Deswal

C

Clifton Fuller

E

Efstratios Koutroumpakis

UT MD Anderson Cancer Center, Houston, Texas, United States